Criteria for the use of omics-based predictors in clinical trials. - Wikidata - wikimedia - TriplyDB

Criteria for the use of omics-based predictors in clinical trials.

Criteria for the use of omics-based predictors in clinical trials.

http://www.wikidata.org/entity/Q34269875

about

Lost in Translation (LiT): IUPHAR Review 6 Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials Methodological requirements for valid tissue-based biomarker studies that can be used in clinical practice Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014 Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures Fluorescence-based assay as a new screening tool for toxic chemicals Translating genomic profiling to gastrointestinal cancer treatment.Bayesian predictive modeling for genomic based personalized treatment selection.Computer Simulation, Bioinformatics, and Statistical Analysis of Cancer Data and Processes Mutation based treatment recommendations from next generation sequencing data: a comparison of web tools Assessment of metabolic phenotypic variability in children's urine using 1H NMR spectroscopy An R package that automatically collects and archives details for reproducible computing.Robust clinical outcome prediction based on Bayesian analysis of transcriptional profiles and prior causal networks Cautionary Note on Using Cross-Validation for Molecular Classification.Benchmarks for detecting 'breakthroughs' in clinical trials: empirical assessment of the probability of large treatment effects using kernel density estimation.Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.Modules, networks and systems medicine for understanding disease and aiding diagnosis.Added predictive value of omics data: specific issues related to validation illustrated by two case studies.Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.OMICS-based personalized oncology: if it is worth doing, it is worth doing well!Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.Molecularly targeted therapies in non-small-cell lung cancer annual update 2014 Cancer biomarker discovery and validation.Cross-validation and Peeling Strategies for Survival Bump Hunting using Recursive Peeling Methods Diabetes and cardiovascular disease: let's push forward with translational research Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials.Using Immune Marker Panels to Evaluate the Role of Inflammation in Cancer: Summary of an NCI-sponsored Workshop.Independent validation test of the vote-counting strategy used to rank biomarkers from published studies.Unbiased Prediction and Feature Selection in High-Dimensional Survival Regression.Preanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic series Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment.In Pursuit of Greater Reproducibility and Credibility of Early Clinical Biomarker Research.Biomarker time out.Pharmacogenomic biomarkers for personalized cancer treatment.Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise.Clinical implications of omics and systems medicine: focus on predictive and individualized treatment.The nephrologist of tomorrow: towards a kidney-omic future.Omics Profiling in Precision Oncology.Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.

P2860

Q24289150-3DA82CD5-B2F3-4B2F-A783-035CA7FBC6E1 Q26776394-A499407C-2C58-4595-961A-DA84626F6DFC Q26996340-9901DFDE-222C-442D-B006-8BF9754D8168 Q27027259-8E90BBB2-88DF-4837-A863-36498D531339 Q28068009-C097D991-F72D-4C59-BEC0-4F5213A30C9F Q28607220-AADBF7E3-8785-43DE-A09D-EA505DA92D12 Q28829380-645993AA-1868-4C8C-8BE8-B1284A513C0F Q30239109-68B2A7B4-68B2-4B3F-B161-AC3E327C93E8 Q30758322-35FB2E68-D284-474A-B7B9-AF471B05530B Q30994089-D04FB95E-C12F-406A-9B2C-667C6D65038F Q31058925-20BB517D-AEED-4126-BB81-9156E52177D3 Q33576589-17C209CB-05FA-42D6-A597-17803A069CCA Q33633460-F93E6A98-28CA-4AAA-8ECC-629E3661A051 Q33760414-BD6F3752-592C-4805-BD43-BE8FB21F0641 Q33816989-C3AE4675-459D-4509-82F5-A886AD3DF3F5 Q34397235-B4517479-A405-41FA-BE38-2620E4A53984 Q34503577-4D68B637-EA75-4D76-A3FE-28BD186FD15C Q34624769-3F83A50E-D609-4025-BBBA-EC91F8138ECF Q34738967-CB62F675-6DCA-4EE3-9CF6-98B3D7563C0F Q35042433-90FE654A-6FB6-4601-93C8-37234885DF55 Q35042467-0C4E93F2-CCDF-4601-9FFE-A1A6CD1DA3D2 Q35127253-B906A554-FD77-4B35-BBF7-DF07814E4052 Q35136424-B89DA702-C4D1-472D-848A-992BDD2864BE Q35879887-6C11EBFF-ED79-4621-BFE4-F3096FDA8690 Q35976189-319F77ED-770D-4036-A542-D485D07599BE Q36174447-F17B8B64-E225-4105-8255-39B9FF47F72E Q36288987-9F1522DB-EA03-49A3-A37E-FE5C8B460609 Q36403297-8FAFBB56-1281-448A-B900-F461B4E6BBCF Q36629665-E8A73A4E-5A34-465C-A695-ADFE7514C54A Q36786055-A42D5AD5-8737-4056-8556-DEA1634EB9C5 Q37296060-9375740E-4633-4024-8EF2-9F5F69791E96 Q37514271-1E48803F-9B8A-497E-B15B-9F157E519FEA Q37708025-940E57BE-4D81-4112-918D-4393E6A0D395 Q38190038-B1DDB60A-C501-459B-9D28-6E87DB76A00A Q38262008-23CB8232-93E3-4FE5-A7AC-2222A9446A59 Q38638963-B77145B7-171E-47AC-A673-AAB5E2B37003 Q38739645-256347F7-9159-44D6-8CFB-B0D8E9CFDD99 Q38767679-E9E90D2A-61DE-4CE3-BA66-2B12591853D2 Q38813546-98B2FBA0-DA59-4FCF-82D1-90A8156EEC0C Q38817134-93722235-D60F-4D6A-8125-BF93712B17BD

P2860

Criteria for the use of omics-based predictors in clinical trials.

http://www.wikidata.org/entity/Q34269875

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Criteria for the use of omics-based predictors in clinical trials.

@ast

Criteria for the use of omics-based predictors in clinical trials.

@en

Criteria for the use of omics-based predictors in clinical trials.

@nl

type

label

Criteria for the use of omics-based predictors in clinical trials.

@ast

Criteria for the use of omics-based predictors in clinical trials.

@en

Criteria for the use of omics-based predictors in clinical trials.

@nl

altLabel

Criteria for the use of omics-based predictors in clinical trials

@en

prefLabel

Criteria for the use of omics-based predictors in clinical trials.

@ast

Criteria for the use of omics-based predictors in clinical trials.

@en

Criteria for the use of omics-based predictors in clinical trials.

@nl

P1433

Q34269875-924C8275-C51A-4830-BCFD-B3275233B797

P1476

Q34269875-3937BACF-55FF-423A-BE0A-B321CDDF95E2

P2093

Q34269875-0EC52784-8766-4EFD-B7C0-ECED41BA57B4

Q34269875-1AD66E97-FEB3-48F3-AAFD-D644EAC84C8B

Q34269875-21D64982-5455-4EB6-AE50-EC070B0487B6

Q34269875-4503E244-6E7C-458B-A586-A01AC91D5621

Q34269875-73E8C0B5-8855-47C6-9A0C-80141D7DB705

Q34269875-7A4FA4E0-B4DB-4861-BBEC-230B2B169EDC

Q34269875-959D0DC3-08E6-4F4A-9B82-3B8EDCDDA870

Q34269875-9B0390D5-8F16-44D2-ADCD-FCDE7775EE17

Q34269875-A2AC35C8-A316-4095-8B51-5F687C11781E

Q34269875-B2D28388-0C6B-4262-9BC3-E435E11CF12C

P2860

Q34269875-01F8DFBB-AFDA-41BB-938A-1292EC05783F

Q34269875-31840869-A16B-4E9C-89F8-32882B5762E9

Q34269875-353E53C0-8FE4-4637-AC51-8DCFDE94EA14

Q34269875-36BD635C-01E9-4D14-A270-1D473196DBFA

Q34269875-602DB280-66D6-45EE-8952-FACEE3536432

Q34269875-8DC5B4B0-6C43-4736-8665-F3B0D09808CD

Q34269875-AC2AD6F7-8725-4057-8C28-C186E1787112

Q34269875-C403007A-18D0-4FD0-9860-7D69B8289277

Q34269875-CBD05FFC-BB73-45D2-9EBE-7B182AAA47CC

Q34269875-DB2B48CA-3D64-4BC2-BCA2-C3681A56C8DA

P2888

Q34269875-7AF33EE1-3331-4810-86BE-70992049A5AB

P304

Q34269875-984D0FBA-FBD5-484B-A6B4-76F98E65BB61

P31

Q34269875-E6702CCF-2513-4362-BA14-B733D99C8F2B

P356

Q34269875-3BE752B5-21CF-478C-91FC-1882CA62C5E2

P407

Q34269875-0D704E78-2AED-407F-B9D1-0BEA76AAE2CD

P433

Q34269875-FB574D9D-0CA3-4704-85B4-E14842229CE1

P478

Q34269875-679E20AC-AC33-4CDA-B88E-F5552D500F9D

P50

Q34269875-2322515E-525E-4507-9816-33829DD2BE5F

P577

Q34269875-42854E53-B9DA-4D5B-B76C-692BC621D047

P5875

Q34269875-392487EB-F066-46CB-B986-31D5D73EAA8C

P6179

Q34269875-21B02892-EA7F-4F97-8DEA-602A934AE902

P698

Q34269875-6ABFD4CC-CEA3-4DF0-8BBA-1261F1703313

P932

Q34269875-1C0E8BF6-53B9-4912-965E-9C1F833DBB8E

P356

P1433

P1476

Criteria for the use of omics-based predictors in clinical trials.

@en

P2093

Barbara A Conley

http://www.w3.org/2001/XMLSchema#string

David A Eberhard

http://www.w3.org/2001/XMLSchema#string

Deborah J Shuman

http://www.w3.org/2001/XMLSchema#string

James H Doroshow

http://www.w3.org/2001/XMLSchema#string

James V Tricoli

http://www.w3.org/2001/XMLSchema#string

Jeremy M G Taylor

http://www.w3.org/2001/XMLSchema#string

Kelly Y Kim

http://www.w3.org/2001/XMLSchema#string

Lisa M McShane

http://www.w3.org/2001/XMLSchema#string

Margaret M Cavenagh

http://www.w3.org/2001/XMLSchema#string

Mei-Yin C Polley

http://www.w3.org/2001/XMLSchema#string

P2860

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

Tackling the widespread and critical impact of batch effects in high-throughput data

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

Gene expression-based prognostic signatures in lung cancer: ready for clinical use?

Randomized clinical trials with biomarkers: design issues.

Use of archived specimens in evaluation of prognostic and predictive biomarkers

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.

Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting.

Prediction error estimation: a comparison of resampling methods.

Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays.

P2888

P304

317-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE12564

http://www.w3.org/2001/XMLSchema#string

P407

P433

7471

http://www.w3.org/2001/XMLSchema#string

P478

502

http://www.w3.org/2001/XMLSchema#string

P50

Jill P. Mesirov

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257889022

http://www.w3.org/2001/XMLSchema#string

P6179

1015193008

http://www.w3.org/2001/XMLSchema#string

P698

24132288

http://www.w3.org/2001/XMLSchema#string

P932

4180668

http://www.w3.org/2001/XMLSchema#string